Alterations of telomere length and mtDNA copy number are associated with overall survival in hepatocellular carcinoma patients treated with transarterial chemoembolization

被引:0
|
作者
Dengke Bao
Yanna Ba
Feng Zhou
Jing Zhao
Qi Yang
Naijian Ge
Xu Guo
Zhenbiao Wu
Hongxin Zhang
Hushan Yang
Shaogui Wan
Jinliang Xing
机构
[1] Pharmaceutical College of Henan University,Institute of Pharmacy
[2] Fourth Military Medical University,Department of Clinical Immunology, Xijing Hospital
[3] Fourth Military Medical University,Department of General Surgery, Tangdu Hospital
[4] Fourth Military Medical University,State Key Laboratory of Cancer Biology, Experimental Teaching Center of Basic Medicine
[5] Fourth Military Medical University,Department of Pain Treatment, Tangdu Hospital
[6] The Second Military Medical University,Department of Radioactive Intervention, Eastern Hepatobiliary Surgery Hospital
[7] Thomas Jefferson University,Division of Population Science, Department of Medical Oncology, Kimmel Cancer Center
来源
关键词
Telomere length; Mitochondrial DNA; Hepatocellular carcinoma; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:791 / 799
页数:8
相关论文
共 50 条
  • [31] Validation of ABCR and ART scores for predicting overall survival of hepatocellular carcinoma patients treated by transarterial chemoembolization at Hanoi Medical University Hospital
    Pham Minh Duc
    Tran Ngoc Anh
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 185 - 185
  • [32] Low Psoas-Muscle index is associated with decreased survival in hepatocellular carcinoma treated with transarterial chemoembolization
    Zhang, Jin-Xing
    Yan, Hai-Tao
    Ding, Ye
    Liu, Jin
    Liu, Sheng
    Zu, Qing-Quan
    Shi, Hai-Bin
    ANNALS OF MEDICINE, 2022, 54 (01) : 1562 - 1569
  • [33] Survival outcome of hepatocellular carcinoma patients who underwent transarterial chemoembolization
    Corneja, Anna Lyn
    Que, Ernesto
    Morabe, Ferdinand
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A51 - A52
  • [34] NIACE score for hepatocellular carcinoma patients treated by surgery or transarterial chemoembolization
    Adhoute, Xavier
    Penaranda, Guillaume
    Raoul, Jean Luc
    Bollon, Emilie
    Pol, Bernard
    Letreut, Yves P.
    Perrier, Herve
    Bayle, Olivier
    Monnet, Olivier
    Beaurain, Patrick
    Muller, Cyril
    Hardwigsen, Jean
    Lefolgoc, Gaelle
    Castellani, Paul
    Bronowicki, Jean P.
    Bourliere, Marc
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 29 (06) : 706 - 715
  • [35] Time to untreatable progression is an appropriate surrogate endpoint for overall survival in patients with hepatocellular carcinoma after transarterial chemoembolization
    Wang, Hongyu
    Li, Bin
    Wang, Yu
    Zhang, Jiang
    Wu, Yanqin
    Fan, Wenzhe
    Li, Jiaping
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2020, 16 (02) : 301 - 308
  • [36] Association of Serum y-Glutamyl Transpeptidase Levels With Overall Survival in Intermediate and Advanced Hepatocellular Carcinoma Treated With Transarterial Chemoembolization
    Patidar, Yashwant
    Meena, Gaurav
    Mukund, Amar
    Sharma, Manoj K.
    Sarin, Shiv K.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2023, 13 (06) : 934 - 945
  • [37] Diabetes mellitus and the neutrophil to lymphocyte ratio predict overall survival in non-viral hepatocellular carcinoma treated with transarterial chemoembolization
    Zhang, Jiangguo
    Gong, Fengyun
    Li, Ling
    Zhao, Manzhi
    Song, Jianxin
    ONCOLOGY LETTERS, 2014, 7 (05) : 1704 - 1710
  • [38] Copy number profiling of circulating free DNA predicts transarterial chemoembolization response in advanced hepatocellular carcinoma
    Dong, Xiuqing
    Chen, Geng
    Huang, Xinghui
    Li, Zhenli
    Peng, Fang
    Chen, Hengkai
    Zhou, Yang
    He, Lei
    Qiu, Liman
    Cai, Zhixiong
    Liu, Jingfeng
    Liu, Xiaolong
    MOLECULAR ONCOLOGY, 2022, 16 (10) : 1986 - 1999
  • [39] Alteration of telomere length and mtDNA copy number in interstitial lung disease associated with rheumatoid arthritis
    De Benedittis, Giada
    Latini, Andrea
    Morgante, Chiara
    Bonini, Chiara
    Cela, Eneida
    Kroegler, Barbara
    Luciano, Alessandra
    Chiocchi, Marcello
    Cavalli, Francesco
    Ora, Josuel
    Rogliani, Paola
    Novelli, Giuseppe
    Ciccacci, Cinzia
    Chimenti, Maria Sole
    Conigliaro, Paola
    Borgiani, Paola
    AUTOIMMUNITY, 2025, 58 (01)
  • [40] CRAFITY score benefits hepatocellular carcinoma patients treated with transarterial chemoembolization and lenvatinib
    Zhang, Lin
    Yang, Hongcai
    Ning, Shangkun
    Wu, Zhijuan
    Wang, Dianzhe
    Liang, Hexin
    Wang, Chunni
    Chang, Xu
    CANCER MEDICINE, 2024, 13 (12):